InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.36
(
-0.04%
)
Bitcoin
63,679.77
(
-0.88%
)
Post# of 252310
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: caravon post# 169505

Thursday, 11/07/2013 11:49:56 AM

Thursday, November 07, 2013 11:49:56 AM

Post# of 252310

During the today CC, ARQL indicated that Tivantinib in a tablet form has a much higher Pharmacokinetics level (up to 3 times higher) and much higher side-effects.

Just getting ready to listen to CC. Are there plans to amend ongoing P3 HCC to use capsule? Plans for another P3 NSCLC with capsule? Other trials with capsule?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up